Buradasınız

Anasayfa » Content

ESANSÎYEL HİPERTANSİYONDA ERKEN RENAL ETKİLENME GÖSTERGELERİ

EARLY INDICATORS OF RENAL DAMAGE IN ESSENTIAL HYPERTENSION

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 1999

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Essential hypertension (HT) leads to certain functional and structural chances in kidney that possible to detect at early stage. To investigate these effects, our study performed on 209 HT patients with m an age 48.2±9 years. Their systolic and diastolic blood pressure were 159.9^14 and 100.4±8 mmHg. 114 healthy subjects with mean age 46.6±9years were included as controls. Serum uric acid (UA), urinary protein, albumin (UAE), N-acetyl-Q-D-glucosaminidase (NAG), p-2 microglobulin $2M were measured as renal damage indicators. In HT group UA, UAE, NAG (P<0.000), §2M, proteinuria (P<0.005) were higher versus to control. Also,%59 retinopathy (HR) and %28 overt microalbuniuria (MA) were observed. UA was higher in male(P<0.000), serum creatinin (P<0.000), urinary NAG/Cr e atinin, $2M/Creatinin ratio and proteinuria (P<0.05) were higher in female.
Abstract (Original Language): 
Yetişkin populasyonda sık rastlanan ve renal yetmezlik nedenleri arasında önemli yeri olan esansiyel hipertansiyonun (HT) erken evrede böbrek üzerine etkileri belirlenebilmektedir. Bu amaçla renal fonksiyonu normal, yaş ortalaması 48.2±9 yıl, sistolik ve diyastolik kan basıncı 159.9±14 ve 100.4±8 mmHg olan 209 HTlu olgu ve yaş ortalaması 46.6±9 yıl olan 114 sağlıklı birey çalışmaya alındı. Böbrek etkilenme göstergelerinden serum ürik asit (ÜA), idrarda mikroprotein, üriner albumin (ÜAE), N-acetyl-$-D-glucosaminidase (NAG), $-2mikroglobulin ($2M) atılımı araştırıldı, %76'sı hafif- orta düzeyde olan, %59 hipertansif retinopati(HR) ve%28 'nde mikroalbuminüri (MA) saptanan hastalarda ÜA, ÜAE, NAG, (P<0.000) $2M ve proteinüri (P<0.005) kontrol grubundan yüksek bulundu. Erkeklerde ÜA yüksekliğine (P< 0.000) karşı kadın hastalarda serum kreatinin (P<0.000), idrarda NAG/kreatinin ve $2M/kreatinin oranları, proteinüri daha yüksek (P<0.05) bulundu.
FULL TEXT (PDF): 
PDF icon pdf_tndt_260.pdf

REFERENCES

References: 

1. Excerpts fom the USRDS 1998 Annual data report. Am J Kidney Dis. 1998; 32(2)suppll :38-49
2. National high blood pressure education program working group report on hypertension and chronic renal
failure. Arch Intern Med 1991;151:1280-1287
3. Parvihg HH, Jensen HE, Mogensen CE, Evrin PE.
Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974;i344:l 190-1192
4. Palatini P, Graniero GR, Marmino P et al. Prevalence and clinical correlates of microalbuminuria in stage 1 hypertension (HARVEST Study). J Hypertens 1996;9:334-341
5. Mimran A, Ribstein J, DuCailar G. İs microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994;
23(part2):1018-1021
6. Viberti GC, Hill RD, Jarret RJ. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent
diabetes mellitus. Lancet 1982;i: 1430-1432
7- Biesenbach G, Zazgornik J. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin
Nephrol 1994;41(4):211-218
8. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996;14(2):223-228
9. Pontromeli R, Viazzi F, Sofia A et al .Microalbuminuria^ marker of cardiovascular risk and organ demage in essential hypertension. Kidney tnt 1997;52(suppl63):162-165
10. Ruilope LM. Microalbuminuria as risk in essential hypertension. Nephrol Dial Transplant 1997;12(suppl2):2-5
11. Bigazzi R, Bianchi S, Caupese VM, Giorgio B. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension
Nephron 1992;61:94-97
12. Simon G, Morioka S, Snyder DK. Increased serum and urinary N-acetyl—D-glucosaminidase activity in human hypertension: Early indicator of renal dysfunction. Clin
Exp Hyper-theory Practice 1984;A6(4):879-896
13. Abraham PA, Mascioli SR, Launer CA et al. Urinary albumin and N-acetyl—D-glucosaminidase excretions in mild hypertension. Am J Hypertens 1994;7:965-974
14. Agirbasli M, Radhakrishnamurthy B, Jiang X, Bao W, Berenson GS. Urinary N-acetyl—D-glucosaminidase changes in relation to age, sex, race and diastolic and systolic blood pressure in a young adult Biracial population. Am J Hypertens 1996;9:157-161
15. Scarpelli PT, Chega E, Castigli E, Livi R, Cognani M, Cappelli G.Renal handling of albumin and beta-2-microglobulin in human hypertension. Nephron 1985;40:122-123
16. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: An indicator of renal vascular
involvement. Ann Intern Med 1980;93:817-821
17. Wolfson RG, DeWardener HE. Primary renal abnormalities in hereditary hypertension. Kidney
Int.l996;50:717-731
18. Hayakawa H, Coffee K, Raij L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive
hypertension. Circulation 1997;96:2407-2413
19. Bakris GL. Microalbuminuria: prognostic implications.
Curr Opin Nephrol Hypertens 1996;5:219-223
20. Mimran A, Ribstein J, DuCailar G. Microalbuminuria in essential hypertension. Curr Opin Nephrol
Hypertense 1999;8:359-363
21. Perez-Bianco FJ, Ruiz-Martin A, Moreno-Terribas G, Cantero-Hinojasa J. Urinary activity of N-acetyl— glucosaminidase (NAG) in arterial hypertension. Clin
Nephrol 1996;45(l):65-66
22. Pedrinelli R. Microalbuminuria in essential hypertension. A marker of systemic vascular damage?
Nephrol Dial Transplant 1997;12:379-398
23. Reisun E, Messerli FH. Obesity-related hypertension: Mechanism, cardiovascular risk and hereditary. Curr
Opin Nephrol Hypertens 1995;4:67-71
24. Orth SR, Ritz E, Schrier RW.Renal risks of
smoking.Kidney Int 1997;51 (6): 1669-1677

Thank you for copying data from http://www.arastirmax.com